Cargando…

COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study

COVID-19 appears to put people living with HIV and AIDS (PLWHA) at a higher risk of catastrophic consequences and mortality. However, investigations on the hesitancy and vaccination behavior of PLWHA in China were lacking compared to the general population. From January 2022 to March 2022, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Xuan, Zhao, Chaobo, Song, Bing, Huang, Huihuang, Song, Su, Long, Hai, Liu, Weidong, Du, Min, Liu, Min, Liu, Jue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Coronavirus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026882/ https://www.ncbi.nlm.nih.gov/pubmed/36861438 http://dx.doi.org/10.1080/21645515.2022.2151798

Ejemplares similares

People living with HIV /AIDS (PLWHA) and HIV/AIDS associated oral lesions; a study in Malaysia
por: Khan, Saad A, et al.
Publicado: (2012)

Hospitalization and Emergency Room Visits: The Opportunity for Re-Engagement for People Living with HIV/AIDS (PLWHA)
por: Almirol, Ellen, et al.
Publicado: (2017)

Reliability and validity of the Chinese version of the Medical Outcomes Study HIV Health Survey (MOS-HIV) in people living with HIV/AIDS (PLWHA) in China
por: Liu, Jie, et al.
Publicado: (2018)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

HIV/AIDS knowledge and attitude towards people living with HIV/AIDS (PLWHA): a cross-sectional study of primary school teachers
por: Nwimo, Ignatius O, et al.
Publicado: (2020)

Ageing People Living with HIV/AIDS, PLWHA; More Dental Challenges; the Romanian Dental Professional’s Point of View
por: Caministeanu, Florentina, et al.
Publicado: (2023)

1390. Talaromycosis: Differences between Patients with The Anti-interferon-γ Autoantibody and People Living with HIV/AIDS (PLWHA)
por: Krasaewes, Kawisara, et al.
Publicado: (2023)

Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey
por: Qin, Chenyuan, et al.
Publicado: (2023)

Assessing SARS-CoV-2 vaccine hesitancy among the people living with and without HIV from May to September 2022 in Blantyre, Malawi
por: Mchawa, Chifundo, et al.
Publicado: (2023)

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study
por: Zhang, Peize, et al.
Publicado: (2021)

HIV/AIDS Related Stigma and Discrimination against PLWHA in Nigerian Population
por: Dahlui, Maznah, et al.
Publicado: (2015)

Experiences and ways PLWHA deal with their lives
por: Kiwanuka, Anthony, et al.
Publicado: (2021)

Condom use in combination with ART can reduce HIV incidence and mortality of PLWHA among MSM: a study from Beijing, China
por: Tao, Lili, et al.
Publicado: (2018)

Religious coping strategies for people with HIV/AIDS (PLWHA) Muslims in Indonesia: A qualitative study with a telling-the-stories
por: Bukhori, Baidi, et al.
Publicado: (2022)

Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
por: Zhu, Liguo, et al.
Publicado: (2023)

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants
por: Zhao, Zhuxiang, et al.
Publicado: (2022)

COVID-19 vaccine uptake, reasons, and associated factors among older adults in Shenzhen, China
por: Xie, Pei, et al.
Publicado: (2023)

COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study
por: Huang, Min, et al.
Publicado: (2023)

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
por: Shao, Weihao, et al.
Publicado: (2022)

Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation
por: Bei, Zhu-Chun, et al.
Publicado: (2023)

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV
por: Wang, Qian, et al.
Publicado: (2022)

Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study*
por: Song, Rui, et al.
Publicado: (2023)

The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey
por: Wang, Ruitong, et al.
Publicado: (2022)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
por: Liu, Jianyang, et al.
Publicado: (2022)

Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China
por: Zheng, Liwei, et al.
Publicado: (2023)

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Seo, Ji-Min, et al.
Publicado: (2022)

A case–case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants
por: Wu, Dan, et al.
Publicado: (2022)

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study
por: Cao, Cheng, et al.
Publicado: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China
por: Shao, Hui, et al.
Publicado: (2023)

How can COVID-19 vaccines benefit people? A study based on the theory of the commons
por: Su, Yiqing, et al.
Publicado: (2023)

Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR
por: Lu, Shanshan, et al.
Publicado: (2022)

Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?
por: Zhu, Ke-Wei
Publicado: (2023)

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
por: Ai, Jingwen, et al.
Publicado: (2022)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
por: Ma, Chengbao, et al.
Publicado: (2022)

Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing
por: He, Bing, et al.
Publicado: (2022)

Identification of a recombinant equine coronavirus in donkey, China
por: Qi, Peng-Fei, et al.
Publicado: (2022)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
por: Gao, Feixia, et al.
Publicado: (2023)

“In general people aren’t excited about the vaccine…”: Frontline perspectives on COVID-19 vaccine hesitancy across Syria
por: Alhaffar, Mervat, et al.
Publicado: (2023)

The Fertility Status of the Married People Living with HIV/AIDS in China
por: Que, Min, et al.
Publicado: (2022)

The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year
por: Zhang, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsl13e2lqt9u2n71fs8ehuekgb